Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 September 2020 | Story Andre Damons | Photo Charl Devenish
Faculty of Health Sciences donation of PPEs
A group of medical students pose with their new masks, a donation by an alumnus of the Faculty of Health Sciences.

The Faculty of Health Sciences at the University of the Free State (UFS) welcomed the generous donation of 1 000 surgical masks by one of its alumni to aid medical students in this faculty with their clinical training. 

The Professional Provident Society (PPS), a financial services company focused solely on providing intelligent financial solutions for graduate professionals, also donated personal protective equipment (PPE) to the Faculty of Health Sciences.
The first donation was made by Dr Riaan Flooks, a Specialist Physician at Mediclinic Bloemfontein. Dr Flooks received the masks from a friend and decided to donate some of the masks to the UFS. 

Thankful for donations 

Prof Gert van Zyl, Dean: Faculty of Health Sciences, says they are thankful for the donations. 
“All donations help, big or small, and it will help our students to do their tasks and to help where necessary,” Prof Van Zyl said about the second donation by PPS. 
Prof Nathaniel Mofolo, Head: School of Clinical Medicine, expressed his gratitude to Dr Flooks and called him a patron of the university and the faculty.
“On behalf of the School of Clinical Medicine, I hereby wish to express our heartfelt gratitude for your generous contribution and support. This comes at the most needed time and will go a long way in assisting us,” said Prof Mofolo.  
Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at the University of the Free State (UFS), added that the donation of essential PPE to students for use during training in the clinical areas was much appreciated.  
“The support for the academic programme in a practical, tangible way is highly valuable, as it will assist in protecting students while they are in clinical training.”

Doing their bit

According to PPS, one of the positives of the COVID-19 pandemic is the contributions of so many to deal with the crisis – from individuals to big corporates – who want little or nothing in return.  
“We all need to do our bit, and the PPS board has recently decided to contribute R25 million to fight the pandemic in South Africa. In deciding where this would make the biggest impact, our unique positioning among professionals and our relationship with professional associations were considered.”  
“We are also very conscious that health professionals, in particular, are the front-line soldiers in this war, and need to be protected.  It was therefore decided that a major portion of the money will be used to purchase personal protective equipment (PPE) for the safety of medical professionals in both the public and private sectors,” according to PPS.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept